|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang TS, Zheng YJ, Wang J, Zhao JY, Yang
DK and Liu ZS: MicroRNA-506 inhibits tumor growth and metastasis in
nasopharyngeal carcinoma through the inactivation of the
Wnt/β-catenin signaling pathway by down-regulating LHX2. J Exp Clin
Cancer Res. 38:972019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee
NP, Law S, Xu LY, Li EM, Chan KW, et al: MicroRNA-377 suppresses
initiation and progression of esophageal cancer by inhibiting CD133
and VEGF. Oncogene. 36:3986–4000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng Z, Qu JQ, Yi HM, Ye X, Huang W, Xiao
T, Li JY, Wang YY, Feng J, Zhu JF, et al: MiR-125b regulates
proliferation and apoptosis of nasopharyngeal carcinoma by
targeting A20/NF-κB signaling pathway. Cell Death Dis. 8:e28552017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ye SB, Zhang H, Cai TT, Liu YN, Ni JJ, He
J, Peng JY, Chen QY, Mo HY, Jun-Cui, et al: Exosomal miR-24-3p
impedes T-cell function by targeting FGF11 and serves as a
potential prognostic biomarker for nasopharyngeal carcinoma. J
Pathol. 240:329–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bao L, You B, Shi S, Shan Y, Zhang Q, Yue
H, Zhang J, Zhang W, Shi Y, Liu Y, et al: Metastasis-associated
miR-23a from nasopharyngeal carcinoma-derived exosomes mediates
angiogenesis by repressing a novel target gene TSGA10. Oncogene.
37:2873–2889. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Zhong M, Wang J, Wang L, Lin Z, Cao
Z, Huang Z, Zhang F, Li Y, Liu M, et al: miR-301a promotes lung
tumorigenesis by suppressing Runx3. Mol Cancer. 18:992019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu H, Zhang Q, Chen W, Wu T, Liu S, Li X,
Luo B, Zhang T, Yan G, Lu H, et al: MicroRNA-301a promotes
pancreatic cancer invasion and metastasis through the JAK/STAT3
signaling pathway by targeting SOCS5. Carcinogenesis. 41:502–514.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Li J, Cai Y, Peng S, Wang J, Xiao Z,
Wang Y, Tao Y, Li J, Leng Q, et al: Hyperglycaemia-induced miR-301a
promotes cell proliferation by repressing p21 and Smad4 in prostate
cancer. Cancer Lett. 418:211–220. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yue X, Lan F and Xia T: Hypoxic glioma
cell-secreted exosomal miR-301a activates Wnt/β-catenin signaling
and promotes radiation resistance by targeting TCEAL7. Mol Ther.
27:1939–1949. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu J, Liu QH, Wang F, Tan JJ, Deng YQ,
Peng XH, Liu X, Zhang B, Xu X and Li XP: Exosomal miR-9 inhibits
angiogenesis by targeting MDK and regulating PDK/AKT pathway in
nasopharyngeal carcinoma. J Exp Clin Cancer Res. 37:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang YG, Wang T, Shi M and Zhai B: Long
noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma
development by sponging miR-301a-5p and targeting FOXL1. J Exp Clin
Cancer Res. 38:1532019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lettlova S, Brynychova V, Blecha J, Vrana
D, Vondrusova M, Soucek P and Truksa J: MiR-301a-3p suppresses
estrogen signaling by directly inhibiting ESR1 in ERα positive
breast cancer. Cell Physiol Biochem. 46:2601–2615. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia X, Zhang K, Luo G, Cen G, Cao J, Huang
K and Qiu Z: Downregulation of miR-301a-3p sensitizes pancreatic
cancer cells to gemcitabine treatment via PTEN. Am J Transl Res.
9:1886–1895. 2017.PubMed/NCBI
|
|
18
|
Yuniati L, Scheijen B, van der Meer LT and
van Leeuwen FN: Tumor suppressors BTG1 and BTG2: Beyond growth
control. J Cell Physiol. 234:5379–5389. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun GG, Wang YD, Cheng YJ and Hu WN: The
expression of BTG1 is downregulated in nasopharyngeal carcinoma and
possibly associated with tumour metastasis. Mol Biol Rep.
41:5979–5988. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Luo G, Zhang K, Cao J, Huang C,
Jiang T, Liu B, Su L and Qiu Z: Hypoxic tumor-derived exosomal
miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to
promote pancreatic cancer metastasis. Cancer Res. 78:4586–4598.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lan F, Qing Q, Pan Q, Hu M, Yu H and Yue
X: Serum exosomal miR-301a as a potential diagnostic and prognostic
biomarker for human glioma. Cell Oncol (Dordr). 41:25–33. 2018.
View Article : Google Scholar : PubMed/NCBI
|
